Table 6.
Clinical Studies for evaluation of Ivermectin (https://clinicaltrials.gov/ct2/results).
| Clinical Trial Number | Study Description | Phase | Dose | Location |
|---|---|---|---|---|
| NCT04351347 | Evaluating the efficacy of Ivermectin and Nitazoxanide | 2,3 | Not Specified | Egypt |
| NCT04360356 | Evaluating the efficacy of Ivermectin and Nitazoxanide Combination therapy | 2,3 | Ivermectin 200 mcg/kg plus Nitazoxanide 500 mg two times a day for 6 days | Not yet recruiting |
| NCT04343092 | Hydroxychloroquine and Azithromycin with an adjunct of Ivermectin | 1 | Ivermectin 0.2 mg/kg (single dose at once = 2 tablets of 6mg/weekly) | Iraq |
| NCT04374279 | Clinical Study for Promoting Recovery With Ivermectin or Endocrine Therapy | 2 | Drug: Bicalutamide 150 mg Once a day for 7 days Ivermectin 600 μg/kg once a day for 3 days |
United States |
| NCT04373824 | Ivermectin and Standard of Care Treatment evaluation | Not applicable | Ivermectin 200 to 400mcg/kg first day and the second day was given with standard care | Max Super Speciality Hospital, New Delhi, India |